D-Index & Metrics Best Publications
Christian Hölscher

Christian Hölscher

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 79 Citations 19,132 255 World Ranking 12522 National Ranking 128

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Neuron
  • Neuroscience

Christian Hölscher spends much of his time researching Endocrinology, Internal medicine, Long-term potentiation, Liraglutide and Neuroprotection. His Endocrinology research incorporates themes from Alzheimer's disease and Neurodegeneration. His Pharmacology research extends to Internal medicine, which is thematically connected.

His Long-term potentiation research is multidisciplinary, relying on both Synaptic plasticity, Hippocampus, Neuroscience and Neurotransmission. The concepts of his Liraglutide study are interwoven with issues in Incretin and Exenatide. His studies in Neuroprotection integrate themes in fields like Signal transduction, Kinase, GSK-3 and Receptor expression.

His most cited work include:

  • Aβ42‐driven cerebral amyloidosis in transgenic mice reveals early and robust pathology (602 citations)
  • An anti-diabetes agent protects the mouse brain from defective insulin signaling caused by Alzheimer’s disease–associated Aβ oligomers (526 citations)
  • The Diabetes Drug Liraglutide Prevents Degenerative Processes in a Mouse Model of Alzheimer's Disease (446 citations)

What are the main themes of his work throughout his whole career to date?

His primary areas of study are Internal medicine, Endocrinology, Neuroprotection, Neuroscience and Pharmacology. His Internal medicine study frequently draws connections to adjacent fields such as Protein kinase B. In most of his Endocrinology studies, his work intersects topics such as Alzheimer's disease.

His Neuroprotection research includes elements of Liraglutide, Agonist, Receptor, Neurodegeneration and Parkinson's disease. His Neuroscience research is multidisciplinary, incorporating perspectives in Synaptic plasticity, Long-term potentiation, Neurotransmission and Metabotropic glutamate receptor. His studies deal with areas such as Hippocampal formation and Amyloid as well as Hippocampus.

He most often published in these fields:

  • Internal medicine (46.93%)
  • Endocrinology (46.21%)
  • Neuroprotection (46.57%)

What were the highlights of his more recent work (between 2018-2021)?

  • Neuroprotection (46.57%)
  • Agonist (19.49%)
  • Internal medicine (46.93%)

In recent papers he was focusing on the following fields of study:

His primary areas of investigation include Neuroprotection, Agonist, Internal medicine, Pharmacology and Endocrinology. His Neuroprotection study introduces a deeper knowledge of Neuroscience. The study incorporates disciplines such as Liraglutide, Incretin, PER2 and Circadian rhythm in addition to Agonist.

Christian Hölscher works in the field of Internal medicine, focusing on Peroxisome proliferator-activated receptor in particular. He has included themes like Substantia nigra, GIP receptor, DUAL and Tumor necrosis factor alpha in his Pharmacology study. His Endocrinology study integrates concerns from other disciplines, such as Synaptic plasticity, Long-term potentiation and Cerebral infarction.

Between 2018 and 2021, his most popular works were:

  • Insulin Signaling Impairment in the Brain as a Risk Factor in Alzheimer's Disease. (27 citations)
  • Brain insulin resistance: role in neurodegenerative disease and potential for targeting. (23 citations)
  • Semaglutide is Neuroprotective and Reduces α-Synuclein Levels in the Chronic MPTP Mouse Model of Parkinson's Disease. (20 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Neuron
  • Neuroscience

Christian Hölscher mainly focuses on Neuroprotection, Pharmacology, Agonist, Liraglutide and Receptor. He has researched Pharmacology in several fields, including Substantia nigra, Parkinson's disease and MPTP. His Agonist research also works with subjects such as

  • Dopamine, which have a strong connection to Glucagon-like peptide 1 receptor,
  • Incretin and related Water maze, Hippocampus, Streptozotocin, Synaptic plasticity and Neurodegeneration.

He is exploring Water maze as part of his Internal medicine and Endocrinology and Water maze studies. His study in Endocrinology is interdisciplinary in nature, drawing from both Inflammation and Microglia. His Liraglutide study incorporates themes from Reactive oxygen species and Neuroinflammation.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Aβ42‐driven cerebral amyloidosis in transgenic mice reveals early and robust pathology

Rebecca Radde;Tristan Bolmont;Stephan A Kaeser;Janaky Coomaraswamy.
EMBO Reports (2006)

880 Citations

An anti-diabetes agent protects the mouse brain from defective insulin signaling caused by Alzheimer’s disease–associated Aβ oligomers

Theresa R. Bomfim;Leticia Forny-Germano;Luciana B. Sathler;Jordano Brito-Moreira.
Journal of Clinical Investigation (2012)

793 Citations

The Diabetes Drug Liraglutide Prevents Degenerative Processes in a Mouse Model of Alzheimer's Disease

Paula L. McClean;Vadivel Parthsarathy;Emilie Faivre;Christian Hölscher.
The Journal of Neuroscience (2011)

664 Citations

Nitric oxide, the enigmatic neuronal messenger: its role in synaptic plasticity

Christian Hölscher.
Trends in Neurosciences (1997)

566 Citations

Stimulation on the Positive Phase of Hippocampal Theta Rhythm Induces Long-Term Potentiation That Can Be Depotentiated by Stimulation on the Negative Phase in Area CA1 In Vivo

Christian Hölscher;Roger Anwyl;Michael J. Rowan.
The Journal of Neuroscience (1997)

539 Citations

Drugs developed to treat diabetes, liraglutide and lixisenatide, cross the blood brain barrier and enhance neurogenesis.

Kerry Hunter;Christian Hölscher.
BMC Neuroscience (2012)

493 Citations

Intranasal insulin as a treatment for Alzheimer's disease: a review of basic research and clinical evidence.

Jessica Freiherr;Manfred Hallschmid;William H. Frey;Yvonne F. Brünner.
CNS Drugs (2013)

478 Citations

Common pathological processes in Alzheimer disease and type 2 diabetes: a review.

Lin Li;Christian Hölscher.
Brain Research Reviews (2007)

464 Citations

Pharmacological targeting of CSF1R inhibits microglial proliferation and prevents the progression of Alzheimer’s-like pathology

Adrian Olmos-Alonso;Sjoerd T. T. Schetters;Sarmi Sri;Katharine Askew.
Brain (2016)

371 Citations

Liraglutide can reverse memory impairment, synaptic loss and reduce plaque load in aged APP/PS1 mice, a model of Alzheimer’s disease.

Paula L. McClean;Christian Hölscher.
Neuropharmacology (2014)

348 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Christian Hölscher

Fernanda G. De Felice

Fernanda G. De Felice

Federal University of Rio de Janeiro

Publications: 70

Mathias Jucker

Mathias Jucker

University of Tübingen

Publications: 55

Lin Xu

Lin Xu

Kunming Institute of Zoology

Publications: 43

Sergio T. Ferreira

Sergio T. Ferreira

Federal University of Rio de Janeiro

Publications: 41

Bart De Strooper

Bart De Strooper

KU Leuven

Publications: 38

Nigel H. Greig

Nigel H. Greig

National Institutes of Health

Publications: 37

Christian Haass

Christian Haass

Ludwig-Maximilians-Universität München

Publications: 36

Peter R. Flatt

Peter R. Flatt

University of Ulster

Publications: 35

Michael E. Hasselmo

Michael E. Hasselmo

Boston University

Publications: 31

Rudi D'Hooge

Rudi D'Hooge

KU Leuven

Publications: 28

Mark P. Mattson

Mark P. Mattson

Johns Hopkins University School of Medicine

Publications: 28

Edmund T. Rolls

Edmund T. Rolls

University of Warwick

Publications: 26

David M. Holtzman

David M. Holtzman

Washington University in St. Louis

Publications: 25

Denise Manahan-Vaughan

Denise Manahan-Vaughan

Ruhr University Bochum

Publications: 23

Paula I. Moreira

Paula I. Moreira

University of Coimbra

Publications: 21

Javier Vitorica

Javier Vitorica

University of Seville

Publications: 20

Something went wrong. Please try again later.